Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (36)

2024

  1. Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] (Biomedicine & Pharmacotherapy (2022) 150, (S0753332222003547), (10.1016/j.biopha.2022.112965))

    Biomedicine and Pharmacotherapy

  2. Heart Failure Knowledge Assessment and Perceived Patient Satisfaction in Heart Failure Units: A Multicenter Observational Survey

    Reviews in Cardiovascular Medicine, Vol. 25, Núm. 9

  3. Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases

    Medicina Clinica, Vol. 162, Núm. 10, pp. 470-476

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907

  3. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  4. Cognitive versus emotional modulation within a Stroop paradigm in patients with schizophrenia

    BJPsych Open, Vol. 9, Núm. 1

  5. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 151-156

  6. Dramatic increase of suicidality in children and adolescents after COVID-19 pandemic start: A two-year longitudinal study

    Journal of Psychiatric Research, Vol. 163, pp. 63-67

  7. Hospital admissions due to suicide attempts during the COVID-19 pandemic, a 3-year longitudinal study

    Psychiatry Research, Vol. 327

  8. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

  9. Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies

    Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625

2022

  1. Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial

    Frontiers in Pharmacology, Vol. 13

  2. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 150, pp. 112965

  3. Corrigendum to “What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak” [J. Psychiatr. Res. 153 (2022) 104–108, (S0022395622003764), (10.1016/j.jpsychires.2022.07.010)]

    Journal of Psychiatric Research

  4. Dynamics of HIV Reservoir and HIV‐1 Viral Splicing in HCV‐Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  5. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 59

  6. Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  7. Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia

    Journal of Clinical Medicine, Vol. 11, Núm. 4